Insulin Pump Market to Exhibit 8.4% CAGR Globally Says Medtronic, Abbott by 2023
The Insulin Pump is a device garnering huge popularity worldwide, owing to the advancement in the physiologic programmable technique for insulin delivery which has made these pumps adaptable and lifestyle friendly. Continuous subcutaneous insulin infusion (CSII) is a therapy which uses insulin pumps to deliver insulin to diabetics. Over a certain period, along with the technological advancements, these pumps have evolved significantly from constant observing glucose sensors that give exceptional access to the patient's blood glucose levels to "sensor-augmented" and...
View full press release